RACGP examiner reports · fix it Running out of time Spending too long on early questions and rushing or skipping the rest.
What it looks like: Long vignettes eat time. Candidates read every word twice, reconsider, and arrive at the last questions with minutes to spare, which costs more marks than any single topic.
How to fix it: Set a time per question from the paper's length and stick to it. On long stems read the last line first, then read the stem for what it asks. Mark your best answer, flag it, and move on.
The drill: 15 questions Questions from the General practice bank picked because they test this habit. You answer one at a time and see the explanation straight away. Aim for about 96 seconds each, the pace of the real paper.
The first 3 are free, below and in the drill with a free account. Any General practice plan opens all 15.
Try 3 now. No account needed. Question 1 of 3 Older persons' health
A retrospective cohort study examined statins for primary prevention in adults aged 75 and over, with and without type 2 diabetes. Hazard ratios (statin users versus non users, with 95% CI) were plotted against age. Without diabetes, the hazard ratios for atherosclerotic cardiovascular disease and for all cause mortality lay close to 1.0 from age 75 to 95 with confidence intervals crossing 1 throughout. With diabetes, the hazard ratio for atherosclerotic disease was about 0.7 at 75, rising to 0.8 at 85, with the upper confidence limit below 1 until about age 85, then rising above 1 by 95 with very wide intervals. With diabetes, the mortality hazard ratio rose from about 0.8 at 75 to 1.2 at 95, with the upper confidence limit below 1 only near age 75. What is the best conclusion from these data? A People over 90 have an increased mortality risk from statins B People without diabetes aged 75 to 85 have a reduced risk of atherosclerotic disease on statins C People with diabetes aged under 85 have an increased risk of atherosclerotic disease on statins D People without diabetes aged 75 to 85 have reduced all cause mortality on statins E People with diabetes aged under 85 have a reduced risk of atherosclerotic disease on statins
Pick an answer to see the explanation. Next question →
Question 1 of 3 · Older persons' health
A retrospective cohort study examined statins for primary prevention in adults aged 75 and over, with and without type 2 diabetes. Hazard ratios (statin users versus non users, with 95% CI) were plotted against age. Without diabetes, the hazard ratios for atherosclerotic cardiovascular disease and for all cause mortality lay close to 1.0 from age 75 to 95 with confidence intervals crossing 1 throughout. With diabetes, the hazard ratio for atherosclerotic disease was about 0.7 at 75, rising to 0.8 at 85, with the upper confidence limit below 1 until about age 85, then rising above 1 by 95 with very wide intervals. With diabetes, the mortality hazard ratio rose from about 0.8 at 75 to 1.2 at 95, with the upper confidence limit below 1 only near age 75. What is the best conclusion from these data?
People over 90 have an increased mortality risk from statins People without diabetes aged 75 to 85 have a reduced risk of atherosclerotic disease on statins People with diabetes aged under 85 have an increased risk of atherosclerotic disease on statins People without diabetes aged 75 to 85 have reduced all cause mortality on statins People with diabetes aged under 85 have a reduced risk of atherosclerotic disease on statins Show the answer E. People with diabetes aged under 85 have a reduced risk of atherosclerotic disease on statins
The only finding where the point estimate is below 1 and the confidence interval excludes 1 across the stated age range is the reduction in atherosclerotic cardiovascular disease in people with type 2 diabetes up to about 85 years. This matches the published study (Ramos et al), which found statin use in diabetic patients aged 75 to 84 was associated with fewer cardiovascular events, with the benefit waning after 85 and absent in nonagenarians, while no benefit was seen in people without diabetes. In that paper's categorical analysis, people with diabetes aged 75 to 84 also had lower all cause mortality (HR 0.84), but the plotted curve shows the mortality interval crossing 1 beyond the late 70s, so the atherosclerotic disease benefit is the most robust conclusion from these graphs and that distractor was deliberately replaced. Although the point estimate for mortality above 90 in diabetes is over 1, the very wide confidence intervals cross 1, so harm cannot be concluded. An increased atherosclerotic risk under 85 contradicts the curve, which is below 1. In people without diabetes the mortality hazard ratio sits near 1 with intervals crossing 1, so no mortality benefit is shown. In Australian practice, statin decisions in people over 75 are individualised, as the Australian CVD risk calculator is not validated above 79. References: Ramos R et al. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study. BMJ 2018;362:k3359. Commonwealth of Australia. Australian guideline for assessing and managing cardiovascular disease risk, 2023.
Why not A: Confidence intervals above 90 are very wide and cross 1, so harm is not demonstrated. Why not B: In people without diabetes the atherosclerotic disease hazard ratio is near 1 with intervals crossing 1, so no benefit is shown. Why not C: The hazard ratio is below 1 in this group, indicating reduced, not increased, risk. Why not D: In people without diabetes the mortality hazard ratio is near 1 with intervals crossing 1, so no benefit is shown. Question 2 of 3 · Children and young people's health
A 15-year-old girl lives in a rural town where you run a monthly paediatric outreach clinic. For a year, anxiety has stopped her attending school. Away from home she feels dread with palpitations, sweating and chest heaviness. She has trouble falling asleep and frequent nightmares, worries about germs and washes her hands often, and fears something bad will happen if she records over her old videos, though she knows these thoughts are silly. She previously did well at school and had many friends. Her mother died eight years ago and there is no family psychiatric history. She refuses to see a psychiatrist but will keep seeing you. In addition to psychological therapy, which one of the following medications is most appropriate?
Amitriptyline Clomipramine Oxazepam Sertraline Paroxetine Show the answer D. Sertraline
This adolescent has obsessive-compulsive disorder with prominent panic and agoraphobic avoidance. Cognitive behavioural therapy with exposure and response prevention is first-line, and when symptoms are moderate to severe or therapy alone is insufficient, a selective serotonin reuptake inhibitor is added. Sertraline and fluoxetine are preferred in young people, sertraline having good trial evidence in paediatric OCD (POTS) and TGA approval for OCD from six years of age. Paroxetine is not recommended under 18 years because of poor efficacy and an increased risk of suicidality. Clomipramine is effective for OCD but is second-line because of anticholinergic effects, ECG changes and toxicity in overdose. Amitriptyline has no role in paediatric anxiety or OCD and is dangerous in overdose. Benzodiazepines such as oxazepam do not treat OCD and risk dependence and disinhibition, so are avoided in adolescents. Monitoring for agitation and suicidal thinking early in SSRI treatment is required. References: Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder. JAMA 2004;292:1969-76; National Institute for Health and Care Excellence. Obsessive-compulsive disorder and body dysmorphic disorder: treatment. CG31, 2005.
Why not A: Amitriptyline has no role in paediatric anxiety or OCD and is highly toxic in overdose. Why not B: Clomipramine is effective for OCD but is second-line because of adverse effects and overdose toxicity. Why not C: Benzodiazepines do not treat OCD and risk dependence and disinhibition in adolescents. Why not E: Paroxetine is not recommended under 18 years because of poor efficacy and increased suicidality. Question 3 of 3 · Gastrointestinal and liver health
A 66-year-old man has had a week of itch and dark urine. He has no abdominal pain or fever. Three weeks ago he finished a seven-day course of amoxicillin-clavulanate for sinusitis. He drinks about four standard drinks a week. He is jaundiced and his abdomen is soft and non-tender. Bilirubin is 90 micromol/L (conjugated 72), ALP 450 U/L (reference below 110), GGT 600 U/L (below 60) and ALT 150 U/L (below 40). Ultrasound shows no gallstones, a common bile duct of 4 mm and a normal pancreas. Hepatitis A, B, C and E serology is negative. What is the most likely diagnosis?
Choledocholithiasis Primary sclerosing cholangitis Drug-induced liver injury Pancreatic head carcinoma Primary biliary cholangitis Show the answer C. Drug-induced liver injury
His tests are cholestatic or mixed: ALP over four times and ALT under four times the upper limit, with a conjugated hyperbilirubinaemia. A normal-calibre duct and normal pancreas make extrahepatic obstruction unlikely, and viral serology is negative. The key is timing: amoxicillin-clavulanate is the commonest cause of idiosyncratic drug-induced liver injury in Australian and international series, typically in men over 55, and characteristically presents one to several weeks after the course has finished, so the link is easily missed. The clavulanate component is responsible. A stone remains the strongest alternative, but painless onset with a 4 mm duct argues against it; MRCP is reasonable if doubt persists. Most patients recover over weeks to months, though cholestasis can be prolonged. Liver tests should be followed to normal and the reaction recorded as an adverse drug reaction.
Why not A: Duct stones usually cause biliary pain and fever, and a cholestatic picture this marked would usually come with a dilated duct; his duct is 4 mm and he has no pain. Why not B: Sclerosing cholangitis is usually found in younger men with inflammatory bowel disease and develops insidiously, not as jaundice within weeks of a course of treatment. Why not D: Painless jaundice in an older man raises this concern, but distal biliary obstruction would dilate the duct, and the pancreas looks normal. Why not E: Primary biliary cholangitis is a disease mainly of middle-aged women that evolves over years, usually with itch and fatigue long before jaundice. Create a free account to save your results and keep going →
Where the RACGP examiners flagged it All RACGP examiner reports →
Fellowship Ready is not affiliated with or endorsed by the RACGP. Not affiliated with the RACGP.